These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 3491925

  • 1. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice.
    Young MR, Newby M.
    J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925
    [Abstract] [Full Text] [Related]

  • 2. Effects of fish oil and corn oil diets on prostaglandin-dependent and myelopoiesis-associated immune suppressor mechanisms of mice bearing metastatic Lewis lung carcinoma tumors.
    Young MR, Young ME.
    Cancer Res; 1989 Apr 15; 49(8):1931-6. PubMed ID: 2522813
    [Abstract] [Full Text] [Related]

  • 3. Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors.
    Young MR, Newby M, Wepsic HT.
    Cancer Res; 1987 Jan 01; 47(1):100-5. PubMed ID: 2947676
    [Abstract] [Full Text] [Related]

  • 4. Regulation of tumor-induced myelopoiesis and the associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma by prostaglandin E2.
    Young MR, Young ME, Kim K.
    Cancer Res; 1988 Dec 01; 48(23):6826-31. PubMed ID: 2972359
    [Abstract] [Full Text] [Related]

  • 5. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
    Young MR, Young ME, Wepsic HT.
    Cancer Res; 1987 Jul 15; 47(14):3679-83. PubMed ID: 3109729
    [Abstract] [Full Text] [Related]

  • 6. Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants.
    Young MR, Aquino S, Young ME.
    J Leukoc Biol; 1989 Mar 15; 45(3):262-73. PubMed ID: 2522492
    [Abstract] [Full Text] [Related]

  • 7. Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.
    Young MR, Duffie GP, Lozano Y, Young ME, Wright MA.
    Cancer Res; 1990 May 15; 50(10):2973-8. PubMed ID: 2159367
    [Abstract] [Full Text] [Related]

  • 8. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. II. Mechanisms for induction of suppression.
    Ting CC, Hargrove ME.
    J Natl Cancer Inst; 1982 Oct 15; 69(4):873-8. PubMed ID: 6214654
    [Abstract] [Full Text] [Related]

  • 9. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma.
    Young MR, Wheeler E, Newby M.
    J Natl Cancer Inst; 1986 Apr 15; 76(4):745-50. PubMed ID: 3457207
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma.
    Young MR, Hoover CS.
    J Natl Cancer Inst; 1986 Aug 15; 77(2):425-9. PubMed ID: 2942724
    [Abstract] [Full Text] [Related]

  • 11. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF.
    Fu YX, Watson GA, Kasahara M, Lopez DM.
    J Immunol; 1991 Jan 15; 146(2):783-9. PubMed ID: 1824777
    [Abstract] [Full Text] [Related]

  • 12. Adhesiveness and morphology of Lewis lung carcinoma variants influence their sensitivity to natural killer cytolysis and their metastatic capacity.
    Young MR, Duffie GP, Newby M.
    Invasion Metastasis; 1987 Jan 15; 7(2):96-108. PubMed ID: 3583624
    [Abstract] [Full Text] [Related]

  • 13. Suppressor alveolar macrophages in mice bearing metastatic Lewis lung carcinoma tumors.
    Young MR, Endicott RA, Duffie GP, Wepsic HT.
    J Leukoc Biol; 1987 Dec 15; 42(6):682-8. PubMed ID: 3500255
    [Abstract] [Full Text] [Related]

  • 14. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis.
    Lala PK, Parhar RS, Singh P.
    Cell Immunol; 1986 Apr 15; 99(1):108-18. PubMed ID: 2944621
    [Abstract] [Full Text] [Related]

  • 15. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
    Dussault I, Miller SC.
    Nat Immun; 1993 Apr 15; 12(2):66-78. PubMed ID: 8318817
    [Abstract] [Full Text] [Related]

  • 16. Modification of host antitumor defense mechanisms in mice by progressively growing tumor.
    Maccubbin DL, Mace KF, Ehrke MJ, Mihich E.
    Cancer Res; 1989 Aug 01; 49(15):4216-24. PubMed ID: 2525950
    [Abstract] [Full Text] [Related]

  • 17. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG, Burger CJ, Elgert KD.
    J Immunol; 1994 Aug 15; 153(4):1674-86. PubMed ID: 8046239
    [Abstract] [Full Text] [Related]

  • 18. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.
    Ting CC, Rodrigues D.
    J Natl Cancer Inst; 1982 Oct 15; 69(4):867-72. PubMed ID: 6214653
    [Abstract] [Full Text] [Related]

  • 19. The effect of recombinant murine interferon-gamma on the hematopoietic and immunological parameters of mice bearing metastatic Lewis lung carcinoma tumors.
    Young MR, Young ME, Wepsic HT.
    Exp Hematol; 1988 May 15; 16(4):295-301. PubMed ID: 2966070
    [Abstract] [Full Text] [Related]

  • 20. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS, Ip G, Wright MA, Young MR.
    Cancer Res; 1995 Feb 15; 55(4):885-90. PubMed ID: 7850804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.